Published March 22, 2011
| Version v1
Patent
Open
Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
A novel group of gastrokines called Gastric Antrum Mucosal Protein is characterized. A member of the group is designated AMP-18. AMP-18 genomic DNA, cDNA and the AMP-18 protein are sequenced for human, mouse and pig. The AMP-18 protein and active peptides derived from it are cellular growth factors. Surprisingly, peptides capable of inhibiting the effects of the complete protein, are also derived from the AMP-18 protein. Cytoprotection and control of mammalian gastro-intestinal tissue growth and repair (restitution) is facilitated by the use of the proteins, making the proteins candidates for therapies in inflammatory bowel disease, mucositis, and gastric ulcers.
Files
US7910543.pdf
Files
(2.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:3f82018ff67f72236587421cd3f9acf1
|
2.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 60460909 A
- Patent number
- US 7910543 B2
- Other
- oai:uchicago.tind.io:9322
Dates
- Patent filed
-
2009-10-23